184 results
8-K
QLGN
Qualigen Therapeutics Inc
30 May 24
Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination
4:00pm
of 15 days from the date of the request. The Company also intends to seek an extended stay pending the hearing, although no assurance can be provided … on the Nasdaq Capital Market and intends to submit a plan to that effect to the Panel as part of the hearing process; however, there can be no assurance
8-K
EX-99.1
QLGN
Qualigen Therapeutics Inc
30 May 24
Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination
4:00pm
, although no assurance can be provided that such an extension would be granted.
The Company is working to evidence compliance with all applicable … , there can be no assurance the Panel will grant any request for continued listing or that the Company will be able to regain compliance
424B3
QLGN
Qualigen Therapeutics Inc
3 May 24
Prospectus supplement
1:50pm
prospectus that we have authorized. We take no responsibility for, and can provide no assurance as to the reliability of, any other information
POS AM
QLGN
Qualigen Therapeutics Inc
30 Apr 24
Prospectus update (post-effective amendment)
6:58pm
no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. The shares are not being
8-K
EX-10.4
7680tj1
16 Apr 24
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-10.1
2sn2p4w4ovhsof5iw
27 Feb 24
Entry into a Material Definitive Agreement
7:00am
8-K
573lgus2yc8g9
22 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
EX-99.1
we38fncyzc rlwgpd
14 Nov 23
Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023
5:10pm
8-K
EX-99.1
rr8wx z9rf8bor6b
8 Nov 23
Qualigen Therapeutics Announces First Patient Dosed in the Phase 1a Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors
2:16pm
424B3
bqn0vsro71rd
29 Sep 23
Prospectus supplement
4:30pm
POS AM
ywt5ds48vz v23p8xhk
1 Sep 23
Prospectus update (post-effective amendment)
4:15pm
8-K
EX-99.1
4ruzkqycw1p
15 Aug 23
Results of Operations and Financial Condition
10:04am